Cytokinetics | CYTK - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Amgen USD 540M 1000K 2026-03
Arca Biopharma USD 48.72M 338K 2025-12
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cytokinetics USD 124.43M 2.17M 2026-03
Eisai JPY 282.11M 0 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 253.7M 8.78M 2026-03
Geron USD 640.9M 2.54M 2026-03
Halozyme Therapeutics USD 118.52M 741K 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.47B 12.72M 2025-12
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03